Alpha-1062 for treating traumatic brain injury
AssigneeAlpha Cognition Inc.
InventorDenis G. Kay
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition including a compound ALPHA-1062 or salt thereof, or a compound ALPHA-1062 or salt thereof, for use in the treatment of confirmed or suspected traumatic brain injury (TBI) in a subject. In embodiments, the composition is administered transmucosally, such as intranasally, and/or the composition is self-preserving and anti-microbial. Also disclosed is a multi-use dispenser configured for intranasal or transmucosal administration of a pharmaceutical composition including ALPHA-1062 or salt thereof. Also disclosed is a method of treating traumatic brain injury (TBI) in a subject including administering a therapeutically effective amount of a pharmaceutical composition including ALPHA-1062 or salt thereof.
Claims27
A method for treating a confirmed or suspected traumatic brain injury (TBI) in a subject, comprising administering compound ALPHA-1062 or salt thereof to said subject.
Dependencies are inferred from the claim text.